Medicines like Wegovy and Saxenda, known as 'skinny jabs,' can aid in over 10% weight loss, gaining popularity among celebrities and patients, leading to Novo Nordisk's $4bn investment in production.
Generic versions of weight-loss drugs like Victoza and Saxenda, mimicking gut hormone GLP-1, are being developed by various pharmaceutical companies like Teva, offering lower prices compared to the originals.
[
Collection
]
[
|
...
]